Historical shareholding details of Dimensional US Targeted Value ETF holdings in Design Therapeutics Inc (DSGN)

Monthly changes of Dimensional US Targeted Value ETF shareholding in Design Therapeutics Inc over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Dimensional Us Targeted Value Etf 45,519 0.08%
Mar 28, 2025 Dimensional Us Targeted Value Etf 42,867 0.08%
Mar 27, 2025 Dimensional Us Targeted Value Etf 42,615 0.08%
Feb 28, 2025 Dimensional Us Targeted Value Etf 31,538 0.06%
Feb 26, 2025 Dimensional Us Targeted Value Etf 31,538 0.06%
Jan 31, 2025 Dimensional Us Targeted Value Etf 27,987 0.05%
Jan 30, 2025 Dimensional Us Targeted Value Etf 27,987 0.05%
Jan 29, 2025 Dimensional Us Targeted Value Etf 27,987 0.05%
Dec 31, 2024 Dimensional Us Targeted Value Etf 26,727 0.05%
Dec 30, 2024 Dimensional Us Targeted Value Etf 26,727 0.05%
Nov 29, 2024 Dimensional Us Targeted Value Etf 23,260 0.04%
Nov 28, 2024 Dimensional Us Targeted Value Etf 23,076 0.04%
Oct 31, 2024 Dimensional Us Targeted Value Etf 16,484 0.03%
Oct 30, 2024 Dimensional Us Targeted Value Etf 16,484 0.03%
Sep 30, 2024 Dimensional Us Targeted Value Etf 8,051 0.01%
Sep 26, 2024 Dimensional Us Targeted Value Etf 8,051 0.01%
Aug 30, 2024 Dimensional Us Targeted Value Etf 8,051 0.01%
Aug 29, 2024 Dimensional Us Targeted Value Etf 8,051 0.01%
Jul 31, 2024 Dimensional Us Targeted Value Etf 4,035 0.01%
Jul 29, 2024 Dimensional Us Targeted Value Etf 4,035 0.01%
Jun 28, 2024 Dimensional Us Targeted Value Etf 4,035 0.01%
Jun 27, 2024 Dimensional Us Targeted Value Etf 4,035 0.01%
Mar 13, 2024 Dimensional Us Targeted Value Etf 0 0.00%
Feb 29, 2024 Dimensional Us Targeted Value Etf 4,993 0.01%
Jan 31, 2024 Dimensional Us Targeted Value Etf 4,993 0.01%
Dec 28, 2023 Dimensional Us Targeted Value Etf 4,993 0.01%
Nov 30, 2023 Dimensional Us Targeted Value Etf 4,993 0.01%
Oct 31, 2023 Dimensional Us Targeted Value Etf 4,993 0.01%
Sep 29, 2023 Dimensional Us Targeted Value Etf 4,993 0.01%
Aug 30, 2023 Dimensional Us Targeted Value Etf 4,993 0.01%

View all ownership details of Design Therapeutics Inc